— Know what they know.
Not Investment Advice

SERA NASDAQ

Sera Prognostics, Inc.
1W: +3.0% 1M: -24.0% 3M: -32.8% YTD: -42.0% 1Y: -24.7% 3Y: -49.9%
$1.74
-0.01 (-0.57%)
Pre-Market: $1.80 (+0.06, +3.45%)
Weekly Expected Move ±9.8%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Sell · Power 28 · $66.5M mcap · 28M float · 0.218% daily turnover · Short 35% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$66.5M
52W Range1.37-4.09
Volume16,358
Avg Volume60,024
Beta0.93
Dividend
Analyst Ratings
4 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOZhenya Lindgardt
Employees63
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2021-07-15
2749 East Parleys Way
Salt Lake City, UT 84109
US
801 990 0520
About Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Recent Insider Trades

NameTypeSharesPriceDate
Kearney Paul 0 2026-03-12
Harrison Robert Gard 0 2026-03-12
Boniface John J. 0 2026-03-12
Lindgardt Zhenya A-Award 154,440 2026-03-12
Lindgardt Zhenya A-Award 239,442 $1.99 2026-03-12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms